REmote Virtual Inspiration: Vitality and Energy

Recruiting now · Not applicable

Conditions studied: Implementation Science, Women Health, Disability Physical, Meditation, Tai Chi

In brief

REVIVE is a randomized controlled trial designed to evaluate the effects of a remotely delivered seated Tai Chi/Qigong (TCQ) intervention on cardiometabolic health, stress, sleep, and psychological well-being among women with mobility impairments. Women with mobility impairments experience higher rates of obesity, cardiometabolic disease, chronic stress, sleep disturbances, and mental health concerns compared with women without disabilities. Limited access to accessible physical activity programs and barriers to participation in traditional exercise interventions contribute to these health disparities. Tai Chi and Qigong are gentle mind-body practices that may improve physical and psychological health through movement, breathing, and mindfulness techniques and can be adapted for individuals with limited mobility. Participants will be randomized to either a seated Tai Chi/Qigong intervention or a health education video control condition. During the 12-week intervention phase, participants will receive daily video-based content delivered remotely. Participants assigned to the Tai Chi/Qigong group will engage in seated meditative movement practices, while participants assigned to the control group will receive health and wellness education videos unrelated to physical activity or nutrition behavior change. Outcomes will be assessed remotely at baseline, post-intervention, and follow-up. Primary outcomes include waist circumference and indicators of physiological stress regulation, including heart rate variability and salivary cortisol. Secondary outcomes include perceived stress, emotion regulation, depression, anxiety, emotional eating, sleep quality, and sleep disturbance. Additional measures collected through wearable technology, sleep diaries, questionnaires, and biological samples will be used to examine potential behavioral, psychological, and physiological mechanisms underlying intervention effects. The findings from this study will contribute to the development of accessible, scalable, and evidence-based health promotion interventions designed to improve cardiometabolic health and overall well-being among women with mobility impairments.

Key facts

Study ID

NCT07675681

Run by

Arizona State University

People needed

280

Starts

2026-09-01

Expected to finish

2030-08-30

Last updated by the study team

2026-08-05

Who can join

Age: 35 and older, up to 64. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Self-identify as a woman.
• Age 35-64 years.
• Mobility impairment lasting at least 1 year.
• Regular use of a mobility aid (e.g., wheelchair, scooter, walker, cane, crutches, or other assistive device).
• Community dwelling.
• Able to demonstrate sufficient upper-extremity mobility to participate in seated Tai Chi/Qigong activities.
• Access to a smartphone, tablet, or computer with internet access.
• Willing to wear a study-provided wearable device and complete study assessments.
• Reside in the United States.
• Waist circumference ≥ 33 inches (84 cm).
• Perceived Stress Scale (PSS) score ≥ 15.
• Insomnia Severity Index (ISI) score ≥ 8.
• Emotional eating indicated by a score < 3 on the Mindful Eating Questionnaire (MEQ) Emotional Response subscale.
• Able to understand written and spoken English.
• Able to provide informed consent.
• Able to provide healthcare provider approval for participation.

You may not qualify if…

• Medical conditions that would make participation unsafe, as determined during screening.
• Inability to safely perform seated upper-body movements.
• Current participation in a structured Tai Chi, Qigong, or similar meditative movement program.
• Pregnancy, lactation, or plans to become pregnant during the study period.
• Cognitive, visual, auditory, or other impairments that would preclude completion of study procedures.
• Implanted cardiac devices or implanted electronic devices that interfere with physiologic measurements.
• Severe arrhythmia, left ventricular assist device (LVAD), or other conditions that interfere with heart rate variability assessment.
• Use of sleep medications three or more times per week.
• Medical conditions or medications that substantially affect autonomic nervous system activity, sleep, or stress-related outcomes.
• Uncontrolled cardiovascular, neurological, psychiatric, or other serious medical conditions that would preclude safe participation.

Where it is running

• Arizona State University — Phoenix, Arizona, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.